<SEC-DOCUMENT>0001140361-23-033427.txt : 20230706
<SEC-HEADER>0001140361-23-033427.hdr.sgml : 20230706
<ACCEPTANCE-DATETIME>20230706163119
ACCESSION NUMBER:		0001140361-23-033427
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230703
FILED AS OF DATE:		20230706
DATE AS OF CHANGE:		20230706

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Vazquez Chris
		CENTRAL INDEX KEY:			0001980594

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39659
		FILM NUMBER:		231074009

	MAIL ADDRESS:	
		STREET 1:		2970 WILDERNESS PLACE
		STREET 2:		SUITE 100
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIODESIX INC
		CENTRAL INDEX KEY:			0001439725
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				203986492
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2970 WILDERNESS PLACE
		STREET 2:		SUITE 100
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-417-0500

	MAIL ADDRESS:	
		STREET 1:		2970 WILDERNESS PLACE
		STREET 2:		SUITE 100
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2023-07-03</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001439725</issuerCik>
        <issuerName>BIODESIX INC</issuerName>
        <issuerTradingSymbol>BDSX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001980594</rptOwnerCik>
            <rptOwnerName>Vazquez Chris</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2970 WILDERNESS PLACE</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>BOULDER</rptOwnerCity>
            <rptOwnerState>CO</rptOwnerState>
            <rptOwnerZipCode>80301</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>true</isOfficer>
            <officerTitle>Chief Accounting Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4390</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>20.67</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2031-02-22</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.29</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2032-03-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>11734</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Options (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2033-02-28</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>52034</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F3"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>6619</value>
                    <footnoteId id="F4"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F3"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F5"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F5"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>814</value>
                    <footnoteId id="F5"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F3"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F6"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F6"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>18776</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">This option vested 40% on February 23, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from February 23, 2023.</footnote>
        <footnote id="F2">This option is fully vested.</footnote>
        <footnote id="F3">Each restricted stock unit (&quot;RSU&quot;) represents a contingent right to receive one share of the Issuer's Common Stock.</footnote>
        <footnote id="F4">Represents RSUs remaining from an initial grant of 9,627 RSUs that vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.</footnote>
        <footnote id="F5">Represents RSUs remaining from an initial grant of 4,885 RSUs that vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.</footnote>
        <footnote id="F6">These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez</signatureName>
        <signatureDate>2023-07-06</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>brhc20055519_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-family: 'Times New Roman';">Exhibit 24</font></div>
  <div><br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">POWER OF ATTORNEY</div>
  <div><br>
  </div>
  <div style="text-indent: 36pt; color: rgb(0, 0, 0);">Know all by these presents, that the undersigned hereby makes, constitutes and appoints <u>Robin
        Harper Cowie</u>, with full power of substitution, the undersigned's true and lawful attorney-in-fact to:</div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z19a15638c651480e88fc5f05bc470d2b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; font-family: 'Times New Roman';"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(1)</td>
        <td style="width: auto; vertical-align: top; font-family: 'Times New Roman';">
          <div style="color: rgb(0, 0, 0);">prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) a Form ID, including amendments thereto, and any
            other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the
            SEC;</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z2ea272296d6546f0bcca28537063f2ff" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; font-family: 'Times New Roman';"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(30, 30, 30); font-family: 'Times New Roman';">(2)</td>
        <td style="width: auto; vertical-align: top;">
          <div><font style="font-family: 'Times New Roman'; color: rgb(30, 30, 30);">execute for and on behalf of the undersigned, in the undersigned's
              capacity as an officer and/or director of</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u> Biodesix, Inc.</u>, </font><font style="font-family: 'Times New Roman'; color: rgb(30, 30, 30);">a Delaware corporation (the &#8220;Company&#8221;), Forms 3, 4, and 5, including amendments thereto, in accordance with
              Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations thereunder;</font></div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z8abeba93c10a481b8ce663fb24b0723c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; font-family: 'Times New Roman';"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(30, 30, 30); font-family: 'Times New Roman';">(3)</td>
        <td style="width: auto; vertical-align: top; font-family: 'Times New Roman';">
          <div style="color: rgb(30, 30, 30);">do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or
            amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="zb50e3b406cfc4c64a42c06bc82d4211a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; font-family: 'Times New Roman';"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(30, 30, 30); font-family: 'Times New Roman';">(4)</td>
        <td style="width: auto; vertical-align: top; font-family: 'Times New Roman';">
          <div style="color: rgb(30, 30, 30);">take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
            by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such
            attorney-in-fact may approve in such attorney-in-fact's discretion.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-indent: 36pt; color: rgb(30, 30, 30);">The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and
    thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution
    or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The
    undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the
    Securities Exchange Act of 1934.</div>
  <div><br>
  </div>
  <div style="text-indent: 36pt; font-family: 'Times New Roman', Times, serif;"><font style="font-family: 'Times New Roman'; color: rgb(30, 30, 30);">This Power of Attorney shall remain in full
      force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier (a) revoked by the undersigned </font><font style="font-family: 'Times New Roman'; color: rgb(62, 62, 62);">i</font><font style="font-family: 'Times New Roman'; color: rgb(30, 30, 30);">n a signed writing delivered to the foregoing
      attorney-in-fact or (b) superseded by a new power of attorney regarding the purposes outlined herein at a later date.</font></div>
  <div><br>
  </div>
  <div style="text-indent: 36pt; font-family: 'Times New Roman', Times, serif;"><font style="font-family: 'Times New Roman'; color: rgb(30, 30, 30);">IN WITNESS WHEREOF, the undersigned has
      caused this Power of Attorney to be executed as of this </font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">6 day of June 2023.</font></div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z6bd7fccd1fc14019a5655a8c8e9ce510" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 65%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Chris Vazquez</div>
        </td>
        <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr>
        <td style="width: 65%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman';">
          <div style="text-align: center; color: rgb(30, 30, 30);">Signature</div>
        </td>
        <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr>
        <td style="width: 65%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr>
        <td style="width: 65%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: center; color: rgb(0, 0, 0);">Chris Vazquez</div>
        </td>
        <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr>
        <td style="width: 65%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman';">
          <div style="text-align: center; color: rgb(30, 30, 30);">Print Name</div>
        </td>
        <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
